Inventor
ANDREW RANKIN
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,435,136Antibodies binding to ILT4202512,344,665Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody202512,195,535Antibodies binding to VISTA at acidic pH202512,173,069Antibodies binding to vista at acidic pH202412,091,462Antibodies binding to vista at acidic pH202411,603,406Antibodies binding to VISTA at acidic pH202311,401,328Antibodies binding to ILT4202211,306,150Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (7)· patent assignee history
2022–2025Patents assigned to FIVE PRIME THERAPEUTICS INC (7)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to REGENERON PHARMA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 7 | 2022–2025 |
| FIVE PRIME THERAPEUTICS INC | 7 | 2022–2025 |
| REGENERON PHARMA | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |